vimarsana.com

Latest Breaking News On - Igor khandros - Page 3 : vimarsana.com

Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

Complementary Technologies, Customer Bases, and Commercial Channels to Strengthen Leadership in High-Growth, Single-Cell Biology Significant Cost Synergies to Increase Profitability and Accelerate Breakeven Horizon in 2024, Earlier Than Berkeley Lights E.

Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

RNA biotech Nutcracker Therapeutics unshells $167M for drugs built on biochips

ARCH Venture Partners led the Series C round of financing for Nutcracker Therapeutics, a company developing new RNA drugs. The company’s process for developing and manufacturing RNA therapies borrows from techniques used in the technology sector.

FormFactor (NASDAQ:FORM) vs Taiwan Semiconductor Manufacturing (NYSE:TSM) Financial Review

FormFactor (NASDAQ:FORM – Get Rating) and Taiwan Semiconductor Manufacturing (NYSE:TSM – Get Rating) are both computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings. Risk & Volatility FormFactor has a beta of […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.